Research Paper Volume 12, Issue 24 pp 25395—25411
Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
Figure 5. The association of the SRD5A3 expression and the prognosis of HCC. (A) Overall survival (OS), (B) relapse-free survival (RFS), (C) progression-free survival (PFS) and (D) disease specific survival (DSS) curve based on high and low expression levels of SRD5A3 from the Kaplan–Meier plotter survival analysis platform. (E) Prognostic significance of SRD5A3 expression in HCC in the Human Protein Atlas database. HR, hazard ratio.